Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Nextleaf Solutions
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Report: Canadian cannabis firms received millions in pandemic subsidies
Cannabis businesses in Canada benefited from millions of dollars in pandemic-related subsidies via the federal government, according to research by the publication the Deep Dive and verified by Marijuana Business Daily. Other businesses tapped into int…